Product: Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01
Reason for recall: Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.
Recall initiated: 20180807
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated